Výsledky vyhledávání - "Marta del Campo Milan"

Akademický článek

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Autor: Ananya Chakraborty, Madhurima Chatterjee, Harry Twaalfhoven, Marta Del Campo Milan, Charlotte E. Teunissen, Philip Scheltens, Ruud D. Fontijn, Wiesje M. van Der Flier, Helga E. de Vries

Publikováno v: Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-7 (2018)

Abstract Background Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players involved in the development and

Externí odkaz: https://doaj.org/article/f9ac5a3438e64789afee012dedb42c1f

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

Autor: Marta Del Campo Milan, Leah Zuroff, Connie R. Jimenez, Philip Scheltens, Charlotte E. Teunissen

Publikováno v: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 1, Iss 1, Pp 75-80 (2015)

Abstract The need for effective treatments halting Alzheimer's disease (AD) urges the discovery of the earliest possible biomarkers. Agrin is increased in the early stages of AD and is involved in amyloid‐β (Aβ) fibrillation and synaptogenesis. W

Externí odkaz: https://doaj.org/article/0549503e516b48bea394bf28a28adf77

Zobrazit plný text záznamu

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders

Autor: Yolande A.L. Pijnenburg, Everard G. B. Vijverberg, Charlotte E. Teunissen, Niels D. Prins, Annemiek Dols, Flora Gossink, Cora J. Kerssens, Marta Del Campo Milan, Philip Scheltens, Max L. Stek, Welmoed A. Krudop

Publikováno v: Vijverberg, E G B, Dols, A, Krudop, W A, Del Campo Milan, M, Kerssens, C J, Gossink, F, Prins, N D, Stek, M L, Scheltens, P, Teunissen, C E & Pijnenburg, Y A L 2017, ' Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 7, pp. 99-106 . https://doi.org/10.1016/j.dadm.2017.01.009
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 7, 99-106. Elsevier BV

Introduction To prospectively determine the diagnostic value of cerebrospinal fluid (CSF) levels total-tau (tau) to amyloid-β1–42 ratio (Aβ1–42) ratio (tau/Aβ1–42 ratio), phosphorylated-tau (p-tau) to tau ratio (p-tau/tau ratio), neurofilame

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0abd46eb19e4422596339d0a9da84d6
http://www.scopus.com/inward/record.url?scp=85015215973&partnerID=8YFLogxK

Zobrazit plný text záznamu

CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers

Publikováno v: Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, 10(1). Nature Publishing Group
Scientific Reports, 10(1):8233. Nature Publishing Group
Scientific reports 10(1), 8233 (2020). doi:10.1038/s41598-020-65038-5
Ahmad, S, Milan, M D C, Hansson, O, Demirkan, A, Agustin, R, Sáez, M E, Giagtzoglou, N, Cabrera-Socorro, A, Bakker, M H M, Ramirez, A, Hankemeier, T, Stomrud, E, Mattsson-Carlgren, N, Scheltens, P, van der Flier, W M, Ikram, M A, Malarstig, A, Teunissen, C E, Amin, N & van Duijn, C M 2020, ' CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers ', Scientific Reports, vol. 10, no. 1, 8233 . https://doi.org/10.1038/s41598-020-65038-5
Scientific Reports, 10, 8233. NATURE PUBLISHING GROUP

Many Alzheimer’s disease (AD) genes including Apolipoprotein E (APOE) are found to be expressed in blood-derived macrophages and thus may alter blood protein levels. We measured 91 neuro-proteins in plasma from 316 participants of the Rotterdam Stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adbe6d970e11e7bf515023a81af181a9

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Autor: Wiesje M. van der Flier, Ananya Chakraborty, Madhurima Chatterjee, Helga E. de Vries, Ruud D. Fontijn, Marta Del Campo Milan, Charlotte E. Teunissen, Philip Scheltens, Harry Twaalfhoven

Publikováno v: Chakraborty, A, Chatterjee, M, Twaalfhoven, H, Del Campo Milan, M, Teunissen, C E, Scheltens, P, Fontijn, R D, Van Der Flier, W M & De Vries, H E 2018, ' Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia ', Alzheimer's Research and Therapy, vol. 10, no. 1, 58 . https://doi.org/10.1186/s13195-018-0385-8
Alzheimer's Research and Therapy, 10(1):58. BioMed Central
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-7 (2018)
Alzheimer's Research & Therapy

Background Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players involved in the development and maintena

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e8ac7e0a6c1819410c9dbce7b7352c
https://doi.org/10.1186/s13195-018-0385-8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání